Now that everyone has taken a moment to breathe and maybe a couple of days off after a successful launch of the...

Inflammatory medications are one of the top drivers of specialty drug spend. While these costly drugs can provide...

The pipeline of new drugs coming to market continues to be steady, with 50 novel drugs approved by the FDA in 2021.[1] ...

From continuing revolutionary advancements in gene therapy to the ongoing effects of the COVID-19 pandemic and the...

The member experience is key for Elixir. This means more than a simple letter or access to a member portal. We strive...

An End-of-Year Note from CEO Heyward Donigan

With rising drug costs, we’re all looking for ways to reduce out-of-pocket spend without sacrificing quality. Generic...

Prescription drug spend represented 13.7% of national health expenditures in 2018, totaling $500 billion, and is...

The 2021 audit cycle is coming to a close. The Centers for Medicare and Medicaid Services (CMS) issued its last...

From development of a medication for treatment-resistant HIV with a novel mechanism of action to approval of Pfizer's...